12:00 AM
 | 
Jan 28, 2013
 |  BC Week In Review  |  Company News  |  Deals

Dezima, Mitsubishi Tanabe Pharma deal

Mitsubishi granted Dezima worldwide rights, excluding certain, undisclosed Asian territories, to dyslipidemia compound DEZ-001 (formerlyTA-8995). The

Read the full 77 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >